Nanobusiness News RSS Feed - Nanobusiness

OCSiAl Builds Worldwide Partnership Network

OCSiAl, developer of the revolutionary material TUBALL, is now focused on creating a worldwide partnership network. Facing a growing worldwide demand for new materials and solutions on one side, and a great interest... [More]
Forecast Report on Global Markets for Stretchable Electrics and Electronics

Forecast Report on Global Markets for Stretchable Electrics and Electronics

Stretchable electronics concerns electrical and electronic circuits and combinations of these that are elastically or inelastically stretchable by more than a few percent while retaining function. [More]
STMicroelectronics Announces Open.MEMS Licensing to Boost Time-to-Development

STMicroelectronics Announces Open.MEMS Licensing to Boost Time-to-Development

STMicroelectronics, a global semiconductor leader serving customers across the spectrum of electronics applications, the world's top MEMS (Micro-Electro-Mechanical Systems) manufacturer and the leading supplier of MEMS for consumer and mobile as well as automotive applications, today announced its Open.MEMS program to boost time-to-development with quick and easy single-node evaluation licensing. [More]
FDA Approves Titan Spine’s Next-Generation nanoLOCK Surface Technology

FDA Approves Titan Spine’s Next-Generation nanoLOCK Surface Technology

Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Endoskeleton® line of interbody fusion implants featuring its next-generation nanoLOCKTM surface technology. [More]
Applied Materials Announces Collaboration to Develop Advanced Patterning Solution for Memory Devices

Applied Materials Announces Collaboration to Develop Advanced Patterning Solution for Memory Devices

Applied Materials, Inc. today announced it collaborated with Samsung Electronics Co., Ltd. and PSK Inc., a Korea-based leader in photoresist removal, to develop an advanced patterning solution for the manufacture of future generations of NAND and DRAM device designs. [More]
Electronica 2014: STMicroelectronics Displays Life.Augmented Solutions

Electronica 2014: STMicroelectronics Displays Life.Augmented Solutions

STMicroelectronics, a global semiconductor leader serving customers across the spectrum of electronics applications and Europe's largest semiconductor supplier is showcasing Life.Augmented this week (Nov 11-14) at Electronica in Munich, Hall A5 Booth 207. [More]
Arcturus Therapeutics Takes Part in Second International mRNA Health Conference

Arcturus Therapeutics Takes Part in Second International mRNA Health Conference

Arcturus Therapeutics, Inc., a leading RNA medicines company pursuing orphan diseases, today announced it will present a poster at the 2nd International mRNA Health Conference being held on November 11-12, 2014 in Cambridge, MA. [More]
First Clinical Trial Initiated to Evaluate EnGeneIC’s EDV Nanocells Packaged with microRNAs

First Clinical Trial Initiated to Evaluate EnGeneIC’s EDV Nanocells Packaged with microRNAs

EnGeneIC, Ltd., an emerging biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of cancer therapeutics and other therapeutic molecules, announced today that, together with the Asbestos Disease Research Institute (ADRI), it has initiated the first clinical trial evaluating its bacterially-derived and antibody-guided EDV™ nanocells packaged with microRNA for the treatment of patients with malignant pleural mesothelioma (MPM). [More]
Enrollment Begins in Phase 1 Clinical Trial of Novavax’ RSV F-Protein Nanoparticle Vaccine

Enrollment Begins in Phase 1 Clinical Trial of Novavax’ RSV F-Protein Nanoparticle Vaccine

Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that enrollment has begun in a Phase 1 clinical trial of its respiratory syncytial virus (RSV) F-protein nanoparticle vaccine candidate (RSV F Vaccine), in healthy children, the first study of this vaccine candidate to be conducted in a pediatric population. [More]
New Report Covers Technologies, Applications, and Markets of Biochips and Microarrays

New Report Covers Technologies, Applications, and Markets of Biochips and Microarrays

Research and Markets has announced the addition of a new report "Biochips and Microarrays - Technologies, Markets and Companies" to their offering. [More]